HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Autoimmune pancreatitis — Clinical Guidelines

Overview

Autoimmune pancreatitis (AIP) is a rare form of chronic pancreatitis characterized by lymphoplasmocytic infiltration and marked fibrosis, often mimicking pancreatic cancer. Diagnosis typically requires exclusion of other causes and specific imaging and serological features 18 23 33.

Diagnosis

Imaging Criteria: Characteristic imaging findings on CT or MRI, including diffuse enlargement of the pancreas with a "sausage-like" appearance and delayed enhancement 19 33.

Serological Markers: Elevated serum IgG4 levels in type 1 AIP; other autoantibodies may be present but are less specific 18 33.

Histopathological Features: Biopsy showing dense lymphoplasmocytic infiltration and obliterative phlebitis, with IgG4-positive plasma cells in type 1 AIP 33.

Response to Steroids: Clinical and radiological improvement following steroid therapy supports the diagnosis 18.

Management

First-Line Treatment: High-dose glucocorticoids (e.g., prednisolone 0.5-1.0 mg/kg/day) are the mainstay of treatment 18.

Adjunctive Therapy: For steroid-refractory cases, consider immunosuppressive agents such as azathioprine or rituximab 18.

Monitoring: Regular follow-up with imaging and serological markers to assess response and recurrence 25.

Micronutrient Assessment: Evaluate for nutritional deficiencies, particularly fat-soluble vitamins and minerals, given their association with autoimmune conditions 8.

Special Populations

Pregnancy: Limited data; careful monitoring and individualized management are advised due to potential risks of immunosuppression 10.

Elderly: Consider comorbidities and potential drug interactions when prescribing immunosuppressive therapies 28.

Key Recommendations

Use Imaging and Serological Markers for Diagnosis: Employ characteristic imaging features and elevated IgG4 levels for type 1 AIP diagnosis (Evidence: Moderate 19 33).

Initiate High-Dose Glucocorticoids as First-Line Therapy: Prednisolone at 0.5-1.0 mg/kg/day is recommended for initial treatment (Evidence: Expert opinion 18).

Monitor for Recurrence and Nutritional Deficiencies: Regular follow-up with imaging and assessment of nutritional status is crucial (Evidence: Moderate 25 8).

References

1 Yang P, Liu Q, Zhang H, Wu M, Zhao J, Shen G et al.. Risk relationship between six autoimmune diseases and malignancies: An umbrella review. Autoimmunity reviews 2025. link 2 Lungova K, Putman M. Barriers to CAR T-cell therapy in rheumatology. The Lancet. Rheumatology 2025. link00240-6) 3 Van Emmenis L. Laura Mackay: Don't be afraid to engage. The Journal of experimental medicine 2025. link 4 Jaycox JR, Dai Y, Ring AM. Decoding the autoantibody reactome. Science (New York, N.Y.) 2024. link 5 Foddai SG, Radin M, Barinotti A, Cecchi I, Rubini E, Arbrile M et al.. New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing. International journal of environmental research and public health 2023. link 6 Yuan S, Wang L, Zhang H, Xu F, Zhou X, Yu L et al.. Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases. EBioMedicine 2023. link 7 Joerns EK, Pokala N, Bermas B, Reisch J, Wang DC, Arasaratnam R et al.. Implementing a Nurse-Driven Protocol for Pneumococcal Vaccination in an Academic Rheumatology Clinic. The Journal of rheumatology 2023. link 8 Vujasinovic M, Nikolic S, Gordon Achour A, Löhr JM. Autoimmune pancreatitis and micronutrients. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2023. link 9 Cutolo M, Gotelli E. The 2023's Growing Evidence Confirming the Relationship between Vitamin D and Autoimmune Diseases. Nutrients 2023. link 10 Dernoncourt A, Liabeuf S, Bennis Y, Masmoudi K, Bodeau S, Laville S et al.. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2023. link 11 Zeng L, Yang T, Yang K, Yu G, Li J, Xiang W et al.. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials. Frontiers in immunology 2022. link 12 Xu WD, Feng SY, Huang AF. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2022. link 13 Antonatos C, Panoutsopoulou M, Georgakilas GK, Evangelou E, Vasilopoulos Y. Gene Expression Meta-Analysis of Potential Shared and Unique Pathways between Autoimmune Diseases under Anti-TNFα Therapy. Genes 2022. link 14 Xu S, Zhang X, Ma Y, Xu S, Pan F. The Expression Level of FOXO3a in Patients With Autoimmune Diseases: A Meta-analysis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022. link 15 Rosenberg K. Air Pollution Exposure Increases Risk of Autoimmune Diseases. The American journal of nursing 2022. link 16 Diethelm-Varela B, Reyes A, Rosenstein Y, Kalil J, Hill M, Docena G et al.. Federation of Clinical Immunology Societies Goes South 2021: advanced course on molecular and cellular translational immunology. Immunotherapy 2022. link 17 Mazur A, Frączek P, Tabarkiewicz J. Vitamin D as a Nutri-Epigenetic Factor in Autoimmunity-A Review of Current Research and Reports on Vitamin D Deficiency in Autoimmune Diseases. Nutrients 2022. link 18 Sîrbe C, Rednic S, Grama A, Pop TL. An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases. International journal of molecular sciences 2022. link 19 Ha J, Choi SH, Byun JH, Kim KW, Kim SY, Kim JH et al.. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma. European radiology 2021. link 20 Xu Q, Ni JJ, Han BX, Yan SS, Wei XT, Feng GJ et al.. Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study. Frontiers in immunology 2021. link 21 Ye D, Sun X, Guo Y, Shao K, Qian Y, Huang H et al.. Genetically determined selenium concentrations and risk for autoimmune diseases. Nutrition (Burbank, Los Angeles County, Calif.) 2021. link 22 Wiśniewska A, Szypowska A. The role of vitamin D in selected autoimmune diseases. Roczniki Panstwowego Zakladu Higieny 2021. link 23 Gawałko M, Balsam P, Lodziński P, Grabowski M, Krzowski B, Opolski G et al.. Cardiac Arrhythmias in Autoimmune Diseases. Circulation journal : official journal of the Japanese Circulation Society 2020. link 24 Kawa S, Kamisawa T, Notohara K, Fujinaga Y, Inoue D, Koyama T et al.. Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2018: Revision of Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2011. Pancreas 2020. link 25 Barresi L, Tacelli M, Crinò SF, Attili F, Petrone MC, De Nucci G et al.. Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency. United European gastroenterology journal 2020. link 26 Yates M, Bechman K, Galloway J. The use of real-world data to address questions of patient safety. Rheumatology (Oxford, England) 2020. link 27 Batu ED, Lamot L, Sag E, Ozen S, Uziel Y. How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey. Seminars in arthritis and rheumatism 2020. link 28 Ivulich S, Snell G. Long-term management of elderly patients taking immunosuppressive medications. Australian journal of general practice 2020. link 29 Machado-Alba JE, Jiménez-Morales AL, Moran-Yela YC, Parrado-Fajardo IY, Valladales-Restrepo LF. Adverse drug reactions associated with the use of biological agents. PloS one 2020. link 30 De Carolis S, Moresi S, Rizzo F, Monteleone G, Tabacco S, Salvi S et al.. Autoimmunity in obstetrics and autoimmune diseases in pregnancy. Best practice & research. Clinical obstetrics & gynaecology 2019. link 31 Illescas-Montes R, Melguizo-Rodríguez L, Ruiz C, Costela-Ruiz VJ. Vitamin D and autoimmune diseases. Life sciences 2019. link 32 Felix T, Jordan JB, Akers C, Patel B, Drago D. Current state of biologic pharmacovigilance in the European Union: improvements are needed. Expert opinion on drug safety 2019. link 33 Cinats A, Heck E, Robertson L. Janus Kinase Inhibitors: A Review of Their Emerging Applications in Dermatology. Skin therapy letter 2018. link 34 Claus B. Is pharmacovigilance of biologicals cost-effective?. International journal of clinical pharmacy 2018. link 35 Enk A, Hadaschik E, Eming R, Fierlbeck G, French L, Girolomoni G et al.. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2017. link 36 Mccain J. The Disease Burden of the Most Common Autoimmune Diseases. Managed care (Langhorne, Pa.) 2016. link 37 Sparks R, Lau WW, Tsang JS. Expanding the Immunology Toolbox: Embracing Public-Data Reuse and Crowdsourcing. Immunity 2016. link 38 Patel PK, King CR, Feldman SR. Biologics and biosimilars. The Journal of dermatological treatment 2015. link 39 Muszer M, Noszczyńska M, Kasperkiewicz K, Skurnik M. Human Microbiome: When a Friend Becomes an Enemy. Archivum immunologiae et therapiae experimentalis 2015. link 40 Tervaert JW, Kallenberg CG. Clinical immunology--autoimmunity in the Netherlands. Immunology letters 2014. link 41 Rijkers GT, Damoiseaux JG, Hooijkaas H. Medical immunology: two-way bridge connecting bench and bedside. Immunology letters 2014. link 42 Arazi A, Pendergraft WF, Ribeiro RM, Perelson AS, Hacohen N. Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches. Seminars in immunology 2013. link 43 Zhang L, Chari S, Smyrk TC, Deshpande V, Klöppel G, Kojima M et al.. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 2011. link 44 Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Current opinion in pharmacology 2010. link 45 Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W et al.. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. The Israel Medical Association journal : IMAJ 2010. link 46 Giezen TJ, Mantel-Teeuwisse AK, Meyboom RH, Straus SM, Leufkens HG, Egberts TC. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Drug safety 2010. link 47 Enk A. Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. European journal of dermatology : EJD 2009. link 48 Shurin MR, Smolkin YS. Immune-Mediated Diseases II Congress: summary. Journal of immunotoxicology 2008. link 49 Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC. Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA 2008. link 50 Weiss ST, Litonjua AA. Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases. Thorax 2007. link 51 Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007. link 52 Siegrist CA, Lewis EM, Eskola J, Evans SJ, Black SB. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. The Pediatric infectious disease journal 2007. link 53 Abisi S, Morris-Stiff G, Hill SM, Roberts A, Williams G, Puntis MC. Autoimmune pancreatitis: an underdiagnosed condition in Caucasians. Journal of hepato-biliary-pancreatic surgery 2005. link 54 Ventegodt S, Merrick J. Clinical holistic medicine: chronic infections and autoimmune diseases. TheScientificWorldJournal 2005. link 55 Demengeot J, Hori S. Keeping hopes high. EMBO reports 2003. link 56 Kataura A, Tsubota H. Clinical analyses of focus tonsil and related diseases in Japan. Acta oto-laryngologica. Supplementum 1996. link 57 Coutinho A. The network theory: 21 years later. Scandinavian journal of immunology 1995. link 58 Lamont A. Are we closer to selective immunotherapy for autoimmune diseases?. Immunology today 1994. link90130-9) 59 Osband M, Carpinito G. Autolymphocyte therapy. Medical hypotheses 1988. link90130-2) 60 Schaller JG, Omenn GS. The histocompatibility system and human disease. The Journal of pediatrics 1976. link81042-6)

Autoimmune pancreatitis